• 0

Bobby Marlin, archivist at the Moody Medical Library, and library staff recently received the Trailblazer Award from the Texas Digital Library for their work to digitalize over 2,500 rare anatomical drawings. The renderings give valuable insights into training surrounding anatomy in early Te…

  • 0

Almost every child goes through a stage where he or she is picky about food. You can’t force a child to eat, but luckily picky eating usually improves as a child gets older. It can be frustrating when your child wants to eat the same thing every day or suddenly decides that he or she hates f…

  • 0

A 37-year-old woman named Christin Lipinski developed flu-like symptoms and pain under her armpit that was ultimately found to be caused by an infection with a flesh-eating strain of group A streptococcus bacterium, causing a condition called necrotizing fasciitis. She was taken to the opera…

  • 0

My wife and I just returned from a dream trip to France and the Mediterranean with some indelible memories, awesome photos, great souvenirs, a suitcase of dirty laundry and a respiratory crud that hit us just before we left Rome for home.

  • 0

This past week, I completed my training in medical acupuncture. This course covered the basics tenets of acupuncture and Traditional Chinese Medicine. For many, acupuncture is intimidating and many have questions about it. Let’s talk a bit about what acupuncture is and what it can do.

  • 0

Faculty and residents of the University of Texas Medical Branch’s aerospace medicine programs recently won numerous awards at the Aerospace Medical Association’s annual meeting in Dallas.

  • 0

A recent small pilot study of 600 parents by H. Lim at Cohen Children’s Medical Center of New York found that one in three children ages 0-3 years old showed moderate to severe signs of internet dependence and almost two-thirds showed at least mild signs of digital dependence.

  • 0

For the first time, we have a drug that could help treat a devastating genetic disease called Huntington’s. In an early clinical trial, the drug, Ionis-HTTRx, reduced the levels of the protein whose accumulation in nerve cells is linked to the disorder.